A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation-Reference-Cited by-同舟云学术

A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation

Published:2009 Issue:6 Volume:41 Page:417
ISSN:1226-3613
Container-title:Experimental and Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Cho Kyung-Hyun¹,Kim Jae-Ryong²

Affiliation:

1. School of Biotechnology, Aging-associated Vascular Disease Research Center, Yeungnam University, Gyeongsan 712-749, Korea.

2. Department of Biochemistry and Molecular Biology, Aging-associated Vascular Disease Research Center, Yeungnam University, Daegu 705-717, Korea.

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Reference34 articles.

1. Effect of Up-regulating Individual Steps in the Reverse Cholesterol Transport Pathway on Reverse Cholesterol Transport in Normolipidemic Mice

2. High-Density Lipoprotein Function

3. Antiinflammatory Properties of HDL

4. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay

5. Determination of Uric Acid in Serum by a Carbonate Method

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of the severity of the early formation of the atherosclerotic process in certain pathological forms of coronary heart disease in marine specialists in the conditions of the Arctic region;Arctic and Innovations;2024-06-16

2. Artificial intelligence based identification of the functional role of hirudin in diabetic erectile dysfunction treatment;Pharmacological Research;2021-01

3. Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents;Nanomaterials;2020-05-08

4. Potential of Lipoprotein-Based Nanoparticulate Formulations for the Treatment of Eye Diseases;Biological and Pharmaceutical Bulletin;2020-04-01

5. HDL-Targeted Therapies During Myocardial Infarction;Cardiovascular Drugs and Therapy;2019-02-18